| RS864321676 |
TUBB
|
Health Risk |
Pathogenic |
Multiple benign circumferential skin creases on limbs 1, Multiple benign circumferential skin creases on limbs 1 |
| RS864321677 |
TUBB
|
Health Risk |
Pathogenic |
Multiple benign circumferential skin creases on limbs 1, Multiple benign circumferential skin creases on limbs 1 |
| RS864321678 |
GNMT
|
Health Risk |
Pathogenic |
Glycine N-methyltransferase deficiency, Glycine N-methyltransferase deficiency |
| RS864321679 |
PBRM1
|
Health Risk |
Pathogenic |
Clear cell carcinoma of kidney, Clear cell carcinoma of kidney |
| RS864321680 |
ERF
|
Health Risk |
Pathogenic |
Lambdoidal craniosynostosis, Lambdoidal craniosynostosis |
| RS864321681 |
ERF
|
Health Risk |
Pathogenic |
Lambdoidal craniosynostosis, Lambdoidal craniosynostosis |
| RS864321682 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS864321684 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS864321685 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS864321686 |
COQ7
|
Health Risk |
Pathogenic |
Primary coenzyme Q10 deficiency 8, Primary coenzyme Q10 deficiency 8 |
| RS864321687 |
NUP107
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 11 |
| RS864321688 |
NUP107
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 11 |
| RS864321689 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, Inborn genetic diseases |
| RS864321690 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS864321691 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS864321692 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, Inborn genetic diseases |
| RS864321693 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS864321694 |
AUTS2
|
Health Risk |
Pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS864321695 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS864321697 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS864321698 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321700 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321701 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321702 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321703 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321704 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321705 |
GATA4
|
Health Risk |
Pathogenic |
Congenital heart disease, Congenital heart disease |
| RS864321706 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS864321707 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS864321708 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS864321709 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS864321710 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS864321711 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS864321712 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS864321714 |
TUBB3
|
Health Risk |
Likely pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS864321715 |
TUBB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS864321716 |
TUBB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS864321717 |
TUBB3
|
Health Risk |
Likely pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS864621963 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS864621964 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS864621965 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS864621966 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS864621967 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS864621968 |
TP63
|
Health Risk |
Pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS864621969 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS864621970 |
RUNX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS864621971 |
SALL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS864621972 |
EIF2AK3
|
Health Risk |
Pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS864621973 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS864621974 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS864621975 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621977 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Inborn genetic diseases |
| RS864621978 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621980 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621984 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621986 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621991 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621992 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621993 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621994 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS864621998 |
SPTLC2
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS864622006 |
VPS33B
|
Health Risk |
association |
Arthrogryposis, renal dysfunction |
| RS864622007 |
AR
|
Health Risk |
Likely pathogenic |
Prostate cancer, Prostate cancer |
| RS864622011 |
DNAJC6
|
Health Risk |
Pathogenic |
Prostate cancer, Juvenile onset Parkinson disease 19A |
| RS864622012 |
PPP2CA
|
Health Risk |
Likely pathogenic |
Houge-Janssens syndrome 3, Houge-Janssens syndrome 3 |
| RS864622041 |
MSH6
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS864622043 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS864622046 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS864622051 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS864622056 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622057 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622058 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622059 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622060 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622061 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622063 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS864622064 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS864622065 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS864622073 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS864622079 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS864622082 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS864622083 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS864622086 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS864622088 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell nevus syndrome 1 |
| RS864622090 |
NBN
|
Health Risk |
Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS864622093 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS864622094 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS864622096 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS864622097 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS864622099 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
| RS864622100 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS864622102 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS864622104 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS864622105 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Lynch syndrome 5 |
| RS864622106 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS864622107 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS864622109 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS864622111 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS864622120 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS864622121 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |